24/7 Patient Assistance: 760-405-8205

Johanna Bendell, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information
  • Education & Training


    University of Chicago Pritzker

    Medical School


    Brigham and Women's Hospital



    Brigham and Women's Hospital


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Saint Thomas - Midtown Hospital

    Languages: English/Spanish

    (615) 284-5555

    2000 Church St

    Nashville, Tennessee 37236

    Read More
  • Publications & Memberships

    Dr. Johanna Bendell has contributed to 3 publications.

    Selective targeting of myeloid-derived suppressor cells in cancer patients using DS-8273a, an agonistic TRAIL-R2 antibody.

    Dominguez, G.,Condamine, T. C.,Mony, S.,Hashimoto, A.,Wang, F.,Liu, Q.,Forero, A.,Bendell, J. C.,Witt, R.,Hockstein, N.,Kumar, P.,Gabrilovich, D.; Clin. Cancer Res.. 2016 Dec 15.

    See more >>

    A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors.

    Grilley-Olson JE, Bedard PL, Fasolo A, Cornfeld M, Cartee L, Razak ARA, Stayner L, Wu Y, Greenwood R, Singh R, Lee CB, Bendell J, Burris HA, Del Conte G, Sessa C, Infa...; Invest New Drugs. 2016-12-01.

    See more >>

    Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after ...

    Moore M, Gill S, Asmis T, Berry S, Burkes R, Zbuk K, Alcindor T, Jeyakumar A, Chan T, Rao S, Spratlin J, Tang PA, Rothenstein J, Chan E, Bendell J, Kudrik F, Kauh J, T...; Ann. Oncol.. 2016-12-01.

    See more >>